Genus PLC (GNS)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
2,090.00p
Buy
2,095.00p
30.00p (+1.45%)
Prices updated at 16 May 2025, 17:15 BST
| Prices minimum 15 mins delay
Prices in GBX
Genus PLC focusses on the healthcare sector. It specializes in providing genetic products intended for animals, which allow farmers to produce an enhanced quality of milk products.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Iain George Thomas Ferguson CBE
CEO
Mr. Jorgen Kokke
Most recent earnings
30 Jun 2024
Fiscal year end
30 Jun 2024
Employees
3,573
Head office
Matrix House
Basingstoke
United Kingdom
RG21 4DZ
Key personnel
Owner name | Salary |
---|---|
Ms. Lesley Mary Samuel Knox OBE Non-Executive Director, Senior Independent Director; Workforce Engagement Director | - |
Mr. Iain George Thomas Ferguson CBE Non-Executive Director, Chairman | - |
Mr. Daniel William David Hartley Group General Counsel & Company Secretary | - |
Ms. Alison Jane Henriksen Executive Director, Chief Financial Officer | - |
Mr. Jorgen Kokke Executive Director, Chief Executive Officer | - |
Mr. Stephen David Wilson Executive Director | - |
Top 5 shareholders
Owner name | No. of shares |
---|---|
Wellington Management Company LLP | 2,672,529 |
Capital Research and Management Company | 2,229,203 |
Jupiter Unit Trust Managers Ltd | 2,224,009 |
European Opportunities Trust | 2,224,009 |
Royal London Asset Management Ltd | 2,124,531 |
Director dealings
Date | Action |
---|---|
28 Feb 2025 | Exercise of Option |
28 Feb 2025 | Sale of Option |
16 Sep 2024 | Sale of Option |
16 Sep 2024 | Exercise of Option |
16 Sep 2024 | Sale of Option |
16 Sep 2024 | Exercise of Option |
06 Sep 2024 | Purchase |
05 Sep 2024 | Purchase |
05 Sep 2024 | Purchase |
05 Sep 2024 | Purchase |
05 Sep 2024 | Purchase |
Please note that past performance is not a reliable indicator of future returns.